Literature DB >> 29170179

ANCA-positive IgA nephropathy without necrotising or crescentic glomerulonephritis: a clinical conundrum.

Abhilash Koratala1, Xu Zeng2, Amir Kazory1.   

Abstract

IgA nephropathy, the most prevalent form of primary glomerular disease, usually portends a favourable outcome. Antineutrophil cytoplasmic autoantibodies (ANCAs) have been reported in association with IgA nephropathy in a small subset of patients, mostly presenting with rapidly progressive glomerulonephritis and necrotising crescentic lesions. Herein, we describe a case of IgA nephropathy, positive serum cytoplasmic and perinuclear ANCAs with anti-myeloperoxidase antibody, and preserved renal function without any histological evidence of necrotising or crescentic glomerulonephritis. Based on available mechanistic and clinical data, we opine that such patients could benefit from close monitoring of renal function. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  renal medicine; rheumatology

Mesh:

Substances:

Year:  2017        PMID: 29170179      PMCID: PMC5720328          DOI: 10.1136/bcr-2017-222171

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

2.  Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression.

Authors:  E Allmaras; R Nowack; K Andrassy; R Waldherr; F van der Woude; E Ritz
Journal:  Clin Nephrol       Date:  1997-11       Impact factor: 0.975

3.  Pregnancy Outcomes in "Recovered" Acute Kidney Injury: Underscoring Renal Functional Reserve.

Authors:  Abhilash Koratala; Amir Kazory
Journal:  Nephron       Date:  2017-02-21       Impact factor: 2.847

4.  Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases.

Authors:  M Haas
Journal:  Am J Kidney Dis       Date:  1997-06       Impact factor: 8.860

Review 5.  The commonest glomerulonephritis in the world: IgA nephropathy.

Authors:  G D'Amico
Journal:  Q J Med       Date:  1987-09

6.  ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.

Authors:  M Haas; J Jafri; S M Bartosh; S L Karp; S G Adler; S M Meehan
Journal:  Am J Kidney Dis       Date:  2000-10       Impact factor: 8.860

7.  Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series.

Authors:  Christos Bantis; Maria Stangou; Christoph Schlaugat; Efstathios Alexopoulos; Aphroditi Pantzaki; Dimitrios Memmos; Katrin Ivens; Peter J Heering
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

8.  ANCA and IgA glomerulonephritis all in one: prognosis and complications.

Authors:  Pitchaphon Nissaisorakarn; Vivette D'Agati; Kisra Anis; Belinda Jim
Journal:  BMJ Case Rep       Date:  2017-10-09

9.  MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomy.

Authors:  Noriko Ogawa; Shozo Yano; Yuko Yamane; Masateru Nishiki; Toru Yamaguchi; Tatsuo Tsukamoto; Eri Muso; Toshitsugu Sugimoto
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

10.  MPO-C-ANCA-associated necrotising and crescentic glomerulonephritis.

Authors:  Abhilash Koratala; Dara N Wakefield; Kawther F Alquadan; A Ahsan Ejaz
Journal:  JRSM Open       Date:  2017-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.